Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis

By afschroeder • February 20, 2026

Ahmed M, Zulfiqar E, Hashmi TM, Zia R, Ashraf H, Naveed MA, Ahmed R, Rana JS, Ahmed F, Greene SJ, Fudim M, Mentz RJ, Fonarow GC. Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. ESC Heart Fail. 2026 Feb 3;13(1):xvaf018. doi: 10.1093/eschf/xvaf018. PMID: 41711738.

Tags: Cardiology/Epi, Ferric carboxymaltose, heart failure, iron deficiency, meta-analysis, Publications

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease

Anker SD, Ji L, Kindel T, Coats AJ, Ojji D, Barragán AP, Rossing P, Zieroth S, Ahmad S, Usman S, Appannah G, Bailey AL, Bennis[...]

The frequency and impact of previous admissions within 90 days of subsequent hospitalization for acute myocarditis: An analysis of the Nationwide readmission database

Afzal A, Qureshi A, Bozkurt B, Fonarow GC, Lip GYH, Kwok CS. The frequency and impact of previous admissions within 90 days of subsequent hospitalization[...]

Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]